Sleep disorders. Sleep disorders
Conditions
Interventions
Intervention 1: Intervention of the first group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts. Intervention 2: Intervention of the second gro
Treatment - Drugs
Intervention of the first group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts
Intervention of the second group: receiving a tablet of vitamin E/ 200 Units, orally every day for two months
Intervention of the third group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts and a tablet of vitamin E/ 200 Units, orally every day for two
Control group: No intervention and measuring outcome variables
Sponsors
Research and Technology Vice Chancellor, Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
22 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: to have at least one year of work experience? six night shifts per month? no second job? no history of sleep problems? no special underlying disease such as gland diseases and thyroid? no use of certain medications such as such as benzodiazepines and anticonvulsants, maximum age of 40 years. Exclusion criteria: Intolerance of melatonin or vitamin E?recent history of melatonin or vitamin E for any other reason? a history of intolerance of melatonin or Vitamin E’s oral use? diagnosis of chronic systemic diseases (other than diabetes and hypertension)? and autoimmune disorders? infections? lack of regular drug use within two months of prescribed drugs? lack of consent to participate in the study? the nurses participated in the study who can’t be reachable for the intervention or follow-up were excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Befor intervention and 2 month after start of intervention. Method of measurement: TPR and weight.PSQI.;EEG waves. Timepoint: Befor intervention and 2 month after start of intervention. Method of measurement: Electroencephalogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohsen Ebrahimi Monfared
Arak University of Medical Sciences
Outcome results
None listed